Lindenmeyer Maja T, Hrenn Andrea, Kern Claudia, Castro Victor, Murillo Renato, Müller Stefan, Laufer Stefan, Schulte-Mönting Jürgen, Siedle Bettina, Merfort Irmgard
Institute of Pharmaceutical Science, Department of Pharmaceutical Biology and Biotechnology, University of Freiburg, 79104 Freiburg, Germany.
Bioorg Med Chem. 2006 Apr 15;14(8):2487-97. doi: 10.1016/j.bmc.2005.11.027. Epub 2005 Dec 1.
Twenty-four structurally different SLs were studied for their inhibition on IL-8 production in HeLa229 cells and different IC50-values were obtained. QSAR analyses revealed that the alpha-methylene-gamma-lactone and the presence and reactivity of a second reaction center, expressed by LUMO2, are the most important descriptors for IL-8. Using two SLs as examples, we demonstrated that SLs prevent DNA binding of AP-1, which has binding sites in the IL-8 promoter together with NF-kappaB and C/EBP, and that this is probably due to directly targeting AP-1. p38 MAPK, which plays a role in AP-1 activation as well as in IL-8 regulation, was not influenced by SLs. These data show that NF-kappaB and AP-1, and consequently IL-8 may be interesting targets in antiinflammation research and that the small molecules of SLs may be powerful candidates with promising properties for therapeutic modulation of the inflammatory response.
研究了24种结构不同的SLs对HeLa229细胞中IL-8产生的抑制作用,并获得了不同的IC50值。定量构效关系分析表明,α-亚甲基-γ-内酯以及由LUMO2表示的第二个反应中心的存在和反应性是IL-8最重要的描述符。以两种SLs为例,我们证明了SLs可阻止AP-1与DNA结合,AP-1在IL-8启动子中与NF-κB和C/EBP具有结合位点,这可能是由于直接靶向AP-1所致。p38 MAPK在AP-1激活以及IL-8调节中起作用,但不受SLs影响。这些数据表明,NF-κB和AP-1以及因此的IL-8可能是抗炎研究中有趣的靶点,并且SLs小分子可能是具有调节炎症反应前景特性的有力候选物。